NFAT5 and Duchenne muscular dystrophy: In this study, one DMD (male, 11 years old) and one cell culture from unaffected skeletal muscle fibroblasts (male, 17 years old) used in a previous study [22] were treated with HC or MP, expecting an influence of the GCs treatment on NFAT5 localization and expression in DMD fibroblasts and a possible change in fibroblast proliferation over time.